Opportunities
Browse government tenders, quotations, vacancies and documents across South Africa.
Showing opportunities with a recorded closing date that has not passed. Choose another status to browse historical records.
Ref: SAHPRA/2026/RENEWAL OF VEEAM DATA CLOUD FOR MICROS
SAHPRA invites bids for renewing its Veeam Data Cloud subscription for Microsoft 365 for 36 months, with an option to renew for a further 24 months. The supporting bid document is RFB 006.
- Who it is for:
- ICT service providers
Healthcare professionals and the public may report medical device adverse events and near adverse events to SAHPRA, using the GLF-MD-11A form, and manufacturers and licence holders must report within set timelines.
- Who it is for:
- healthcare professionals, licence holders, manufacturers and the public
- How to act on it:
- Report to SAHPRA's medical device vigilance team at mdvigilance@sahpra.org.za or by telephone on 012 501 0476, using the Medical Device Adverse Event Reporting Form (GLF-MD-11A).
Unregistered ivermectin-containing finished products for human use can be obtained only through SAHPRA's Controlled Compassionate Use Programme, via authorised suppliers.
- Who it is for:
- patients seeking unregistered ivermectin products
- How to act on it:
- obtain the product through an authorised supplier under the Programme
People can report suspected adverse drug reactions to the National Adverse Drug Event Monitoring Centre. The listed contact details are Tel 021 447-1618 and Fax 021 448-6181.
- Who it is for:
- people who have suspected adverse drug reactions and healthcare professionals
- How to act on it:
- Report suspected adverse drug reactions to the National Adverse Drug Event Monitoring Centre by telephone at 021 447-1618 or by fax at 021 448-6181.
Users can use SAHPRA’s website chatbot, Reggie, to find information by typing keywords or asking questions and receiving options in response.
- Who it is for:
- Users of the SAHPRA website
- How to act on it:
- Go to the right-hand side of the SAHPRA home page, select the “Chat with us” button, and type a keyword or ask a question.
People who suspect that a medicine is fake or poor quality can report it to a clinic, pharmacy, or the national medicine regulator.
- Who it is for:
- Consumers or other people who suspect a medicine is fake or poor quality
- How to act on it:
- Report the suspected medicine to a clinic, pharmacy, or national medicine regulator.
SAHPRA and B4SA, under the Pharmaceutical and Vaccines working stream, have made regulatory guidance available to industry. The guidance is intended to ensure essential COVID-19 medicines supply is managed in a clear and transparent manner in both the public and private sectors. Industry is requested to follow the process so SAHPRA can coordinate efforts to address South Africa’s public health COVID-19 medicines needs. A Download PDF link is referenced.
- Who it is for:
- Industry, specifically pharmaceutical and vaccine suppliers, in both the public and private sectors.
- How to act on it:
- Follow the regulatory guidance process set out in the guidance; download the PDF referenced in the SAHPRA News & Updates entry.
A reporting system for health care workers to submit information on benefits and risks of COVID-19 prevention or treatment using therapies outside clinical trials and outside the MEURI framework, including Section 21 unregistered medicines and off-label use of registered medicines. Reports require identifiable patient and reporter, known patient outcome, and identifiable treatment/regimen with start and stop dates. Submission is required after treatment completion or within 1 month, whichever comes first.
- Who it is for:
- health care workers caring for COVID-19 patients
- Who can apply:
- Must be a health care worker caring for COVID-19 patients.; Report must include identifiable patient, identifiable reporter, known patient outcome, and identifiable treatment/regimen with start/stop dates.
- How to act on it:
- Submit reports via the online COVI-Vig portal on the SAHPRA website. Enquiries: covidvig@sahpra.org.za.
People can report side effects associated with cabotegravir to SAHPRA using the MedSafety App.
- Who it is for:
- People reporting side effects from cabotegravir
- How to act on it:
- Report side effects to SAHPRA using the MedSafety App.
SAHPRA makes this handbook available as guidance for reporting adverse events, product quality problems and other health product related issues.
- Who it is for:
- People reporting adverse events, product quality problems or other health product related issues
- How to act on it:
- Open the handbook using the stated document link.
Healthcare professionals and consumers can report adverse reactions associated with the products to the National Adverse Drug Event Monitoring Centre by telephone, fax or mail.
- Who it is for:
- people reporting adverse reactions
- How to act on it:
- Report to NADEMC by telephone on 021 447 1618, by fax on 021 448 6181, or by mail to Department of Health, Registrar of Medicines, Private Bag X828, Pretoria, 0001.
SAHPRA makes available a safety alert warning healthcare professionals and consumers about adverse events linked to prolonged or repeated use of the lindane-containing shampoos Gambex® and Quellada®, and explaining the resulting restrictions and required warnings.
- Who it is for:
- healthcare professionals and consumers
- How to act on it:
- Read the safety alert online at the stated SAHPRA link.